Affichage 31 à 40 des 40 essais cliniques
1 | 2 | 3 | 4 |
1 |
2 |
3 |
4 |
1 | 2 | 3 | 4 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial
CAPTUR/PM.1 NCT03297606  Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Phase II |
Inna Zhylina 514-340-8222 poste 28437 |
|
Étude de phase I sur l’augmentation et l’expansion de la dose évaluant l’innocuité, la pharmacocinétique et l’activité du médicament GDC-6036 chez des patients atteints de tumeurs solides avancées ou métastatiques avec une mutation KRAS G12C
GO42144 NCT04449874 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Ralph Waked 514-340-8222 poste 26823 |
|
|
(EN) An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors
7465-CL-202 (EV-202) NCT04225117 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Sarah Kassis 514-340-8222 poste 22075 |
|
|
(EN) A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
PETRA NCT04644068 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Alessandra Figueiredo De Vasconcelos 514-340-8222 poste 26823 |
|
|
(EN) A phase 1A/B open-label master study of PF-07799544 as a single-agent and in combination with other targeted agents in participants with advanced solid tumors
C4901001 NCT05538130 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Gervais Muhire 514-340-8222 poste 26187 |
|
|
(EN) Spatially Fractionated Radiation (SFR) Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
GRID NCT02333110 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Harielle Lamarre 514-340-8222 poste 26199 |
|
|
(EN) A Phase I-II, First-in-Human Study of SKB264 in Patients With Locally Advanced Unresectable /Metastatic Solid Tumors Who Are Refractory to Available Standard Therapies
KL264-01 NCT04152499 Actif en recrutement
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL SITE GLEN |
Phuong-Nam (Nathalie) Nguyen 514-934-1934 poste 31975 |
|
|
(EN) A Phase 1b Dose Escalation Study of BOLD-100 in Combination With FOLFOX Chemotherapy in Patients With Advanced Solid Tumours
BOLD-100-001 NCT04421820 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Angelica Lara 514-340-8222 poste 24624 |
|
|
(EN) A Phase 2 Basket Study of the Oral TRK Inhibitor Larotrectinib in Subjects With NTRK Fusion-positive Tumors
NAVIGATE NCT02576431 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Sarah Kassis 514-340-8222 poste 22075 |
|
|
(EN) A Phase Ia/Ib, Open Label, Multicenter, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
GO43860 NCT05581004 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Ding Yuan Guo 514-340-8222 poste 24599 |
Groupe d'étude en oncologie du Québec